Concepts (137)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Osteoarthritis, Knee | 17 | 2022 | 381 | 3.800 |
Why?
|
| Osteoarthritis, Hip | 7 | 2019 | 94 | 2.260 |
Why?
|
| Knee Joint | 12 | 2022 | 797 | 2.030 |
Why?
|
| Vibration | 8 | 2018 | 26 | 1.980 |
Why?
|
| Shoes | 6 | 2019 | 29 | 1.740 |
Why?
|
| Gait | 13 | 2019 | 404 | 1.580 |
Why?
|
| Weight-Bearing | 12 | 2018 | 164 | 1.460 |
Why?
|
| Muscle Strength | 5 | 2016 | 127 | 1.380 |
Why?
|
| Pain | 8 | 2022 | 391 | 1.370 |
Why?
|
| Osteoarthritis | 7 | 2018 | 363 | 1.270 |
Why?
|
| Pain Measurement | 6 | 2018 | 462 | 0.970 |
Why?
|
| Proprioception | 3 | 2014 | 19 | 0.940 |
Why?
|
| Walking | 5 | 2019 | 252 | 0.880 |
Why?
|
| Leg | 3 | 2008 | 49 | 0.860 |
Why?
|
| Biomechanical Phenomena | 11 | 2019 | 668 | 0.780 |
Why?
|
| Rheumatology | 4 | 2022 | 81 | 0.750 |
Why?
|
| Orthotic Devices | 3 | 2010 | 23 | 0.720 |
Why?
|
| Middle Aged | 24 | 2019 | 9823 | 0.670 |
Why?
|
| Hyperalgesia | 1 | 2018 | 46 | 0.640 |
Why?
|
| Female | 30 | 2022 | 16197 | 0.620 |
Why?
|
| Pain Management | 3 | 2010 | 143 | 0.610 |
Why?
|
| Sensation | 1 | 2016 | 17 | 0.600 |
Why?
|
| Somatosensory Disorders | 2 | 2018 | 10 | 0.590 |
Why?
|
| Male | 25 | 2019 | 15621 | 0.570 |
Why?
|
| Humans | 38 | 2022 | 29337 | 0.550 |
Why?
|
| Joint Instability | 2 | 2016 | 387 | 0.550 |
Why?
|
| Disease Progression | 7 | 2018 | 787 | 0.520 |
Why?
|
| Exercise Therapy | 4 | 2022 | 112 | 0.520 |
Why?
|
| Foot Orthoses | 1 | 2013 | 11 | 0.460 |
Why?
|
| Aged | 15 | 2019 | 9448 | 0.450 |
Why?
|
| Arthritis, Rheumatoid | 3 | 2020 | 358 | 0.430 |
Why?
|
| Touch | 2 | 2008 | 11 | 0.410 |
Why?
|
| Range of Motion, Articular | 5 | 2018 | 699 | 0.400 |
Why?
|
| Bone Density | 1 | 2011 | 134 | 0.390 |
Why?
|
| Joints | 2 | 2008 | 97 | 0.370 |
Why?
|
| Sensory Thresholds | 4 | 2012 | 24 | 0.370 |
Why?
|
| Antirheumatic Agents | 2 | 2020 | 92 | 0.370 |
Why?
|
| Pressure | 3 | 2019 | 59 | 0.320 |
Why?
|
| Foot | 2 | 2016 | 30 | 0.280 |
Why?
|
| Hip Joint | 3 | 2019 | 367 | 0.260 |
Why?
|
| Severity of Illness Index | 5 | 2018 | 1113 | 0.250 |
Why?
|
| Lupus Erythematosus, Systemic | 2 | 2010 | 202 | 0.250 |
Why?
|
| Musculoskeletal Development | 1 | 2003 | 1 | 0.240 |
Why?
|
| Quadriceps Muscle | 2 | 2016 | 27 | 0.240 |
Why?
|
| Knee | 2 | 2016 | 44 | 0.230 |
Why?
|
| Pilot Projects | 4 | 2017 | 394 | 0.230 |
Why?
|
| Radiography | 2 | 2018 | 678 | 0.230 |
Why?
|
| Rheumatologists | 2 | 2020 | 16 | 0.220 |
Why?
|
| Immunoglobulin G | 1 | 2002 | 129 | 0.200 |
Why?
|
| Gait Disorders, Neurologic | 1 | 2003 | 144 | 0.200 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2002 | 215 | 0.200 |
Why?
|
| Adult | 12 | 2019 | 8601 | 0.190 |
Why?
|
| Feedback, Sensory | 1 | 2019 | 7 | 0.170 |
Why?
|
| Smartphone | 1 | 2019 | 15 | 0.170 |
Why?
|
| Internship and Residency | 1 | 2022 | 211 | 0.170 |
Why?
|
| Cross-Sectional Studies | 3 | 2018 | 959 | 0.160 |
Why?
|
| Cohort Studies | 3 | 2022 | 1939 | 0.160 |
Why?
|
| Absorptiometry, Photon | 2 | 2022 | 76 | 0.150 |
Why?
|
| Arthroplasty, Replacement, Hip | 2 | 2003 | 863 | 0.150 |
Why?
|
| Arthralgia | 1 | 2018 | 121 | 0.150 |
Why?
|
| Phototherapy | 1 | 2017 | 37 | 0.150 |
Why?
|
| Fibromyalgia | 1 | 2017 | 29 | 0.150 |
Why?
|
| Touch Perception | 1 | 2016 | 3 | 0.140 |
Why?
|
| Mechanical Phenomena | 1 | 2016 | 22 | 0.140 |
Why?
|
| Feedback | 1 | 2016 | 31 | 0.140 |
Why?
|
| Auditory Perception | 1 | 2016 | 36 | 0.140 |
Why?
|
| Risk Factors | 5 | 2016 | 2443 | 0.130 |
Why?
|
| Accidental Falls | 1 | 2016 | 116 | 0.130 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2018 | 379 | 0.130 |
Why?
|
| Arthroplasty, Replacement, Knee | 1 | 2002 | 696 | 0.130 |
Why?
|
| Incidence | 1 | 2016 | 756 | 0.120 |
Why?
|
| Aging | 1 | 2003 | 1593 | 0.120 |
Why?
|
| Sensation Disorders | 1 | 2012 | 13 | 0.110 |
Why?
|
| Femoracetabular Impingement | 1 | 2016 | 168 | 0.100 |
Why?
|
| Quality of Life | 2 | 2022 | 662 | 0.100 |
Why?
|
| Perception | 1 | 2012 | 83 | 0.100 |
Why?
|
| Braces | 1 | 2010 | 26 | 0.100 |
Why?
|
| Demography | 1 | 2010 | 77 | 0.090 |
Why?
|
| Menisci, Tibial | 1 | 2012 | 172 | 0.090 |
Why?
|
| Income | 1 | 2010 | 74 | 0.090 |
Why?
|
| Models, Biological | 1 | 2011 | 343 | 0.090 |
Why?
|
| Disability Evaluation | 1 | 2012 | 327 | 0.090 |
Why?
|
| Tendon Injuries | 1 | 2012 | 196 | 0.090 |
Why?
|
| Anterior Cruciate Ligament Injuries | 1 | 2012 | 259 | 0.090 |
Why?
|
| Extremities | 1 | 2008 | 31 | 0.080 |
Why?
|
| Health Status | 1 | 2010 | 227 | 0.080 |
Why?
|
| Orthopedic Procedures | 1 | 2012 | 317 | 0.080 |
Why?
|
| Exercise | 1 | 2012 | 468 | 0.080 |
Why?
|
| Treatment Outcome | 2 | 2013 | 3478 | 0.070 |
Why?
|
| Body Height | 1 | 2006 | 33 | 0.070 |
Why?
|
| Body Weight | 1 | 2006 | 133 | 0.070 |
Why?
|
| Alveolitis, Extrinsic Allergic | 1 | 2005 | 2 | 0.070 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2005 | 26 | 0.070 |
Why?
|
| Aged, 80 and over | 3 | 2016 | 4851 | 0.070 |
Why?
|
| Double-Blind Method | 1 | 2006 | 503 | 0.070 |
Why?
|
| Methotrexate | 1 | 2005 | 41 | 0.070 |
Why?
|
| Lung | 1 | 2005 | 154 | 0.060 |
Why?
|
| Body Mass Index | 1 | 2006 | 428 | 0.060 |
Why?
|
| Etanercept | 1 | 2002 | 23 | 0.050 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2002 | 33 | 0.050 |
Why?
|
| Internal Medicine | 1 | 2022 | 32 | 0.050 |
Why?
|
| Teaching | 1 | 2022 | 62 | 0.050 |
Why?
|
| Physical Examination | 1 | 2022 | 117 | 0.050 |
Why?
|
| Patient Education as Topic | 1 | 2022 | 162 | 0.050 |
Why?
|
| Clinical Competence | 1 | 2022 | 230 | 0.050 |
Why?
|
| Rotation | 1 | 2019 | 142 | 0.040 |
Why?
|
| Healthy Volunteers | 1 | 2019 | 46 | 0.040 |
Why?
|
| Equipment Design | 1 | 2019 | 185 | 0.040 |
Why?
|
| Observer Variation | 1 | 2018 | 118 | 0.040 |
Why?
|
| Young Adult | 2 | 2017 | 1932 | 0.040 |
Why?
|
| Reoperation | 1 | 2002 | 932 | 0.040 |
Why?
|
| Pain Threshold | 1 | 2017 | 20 | 0.040 |
Why?
|
| Predictive Value of Tests | 1 | 2018 | 521 | 0.040 |
Why?
|
| Single-Blind Method | 1 | 2017 | 118 | 0.040 |
Why?
|
| Postoperative Complications | 1 | 2003 | 957 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2018 | 788 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2016 | 227 | 0.030 |
Why?
|
| Circadian Rhythm | 1 | 2017 | 280 | 0.030 |
Why?
|
| Muscle Strength Dynamometer | 1 | 2012 | 15 | 0.030 |
Why?
|
| Weight Lifting | 1 | 2012 | 9 | 0.030 |
Why?
|
| Lower Extremity | 1 | 2012 | 38 | 0.030 |
Why?
|
| Time Factors | 1 | 2017 | 1616 | 0.030 |
Why?
|
| Sweden | 1 | 2012 | 8 | 0.030 |
Why?
|
| Denmark | 1 | 2012 | 12 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2016 | 1442 | 0.030 |
Why?
|
| Chi-Square Distribution | 1 | 2012 | 145 | 0.030 |
Why?
|
| Linear Models | 1 | 2012 | 254 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2016 | 1811 | 0.020 |
Why?
|
| Sickness Impact Profile | 1 | 2010 | 19 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2012 | 638 | 0.020 |
Why?
|
| Social Environment | 1 | 2010 | 79 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2010 | 328 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2012 | 679 | 0.020 |
Why?
|
| Educational Status | 1 | 2010 | 295 | 0.020 |
Why?
|
| Arthroscopy | 1 | 2016 | 811 | 0.020 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2005 | 100 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2005 | 437 | 0.020 |
Why?
|